Chronic mast cell leukemia: a novel leukemia-variant with distinct morphological and clinical features

Leuk Res. 2015 Jan;39(1):1-5. doi: 10.1016/j.leukres.2014.09.010. Epub 2014 Sep 30.

Abstract

Mast cell leukemia (MCL) is a rare form of systemic mastocytosis characterized by leukemic expansion of mostly immature mast cells, organ damage, drug-resistance, and a poor prognosis. Even when treated with chemotherapy, most patients have a life-expectancy of less than one year. However, there are rare patients with MCL in whom the condition is less aggressive and does not cause organ damage within a short time. In these patients, mast cells exhibit a more mature morphology when compared to acute MCL. A recently proposed classification suggests that these cases are referred to as chronic MCL. In the present article, we discuss clinical, histopathological and morphological aspects of acute and chronic MCL.

Keywords: Chronic mast cell leukemia; KIT mutation; Mast cells; Mastocytosis.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acute Disease
  • Chronic Disease
  • Drug Resistance, Neoplasm*
  • Humans
  • Leukemia, Mast-Cell* / classification
  • Leukemia, Mast-Cell* / drug therapy
  • Leukemia, Mast-Cell* / metabolism
  • Leukemia, Mast-Cell* / pathology